ZATZ STEVEN L 4
Research Summary
AI-generated summary
Doximity (DOCS) President Steven Zatz Receives Stock Award
What Happened
Steven L. Zatz, President of Doximity, was granted a derivative award on July 22, 2026 covering 150,000 shares. The Form 4 records the grant as 150,000 shares at $0.00 (derivative), indicating an equity award/option grant rather than an open‑market purchase or sale.
Key Details
- Transaction date: 2026-07-22; Form 4 filed: 2026-07-24 (timely; filed within the typical two-business-day window).
- Transaction type: Award/Grant (derivative) of 150,000 shares; reported price on Form 4: $0.00.
- Vesting: Vests in three equal annual installments beginning July 22, 2027, subject to continuous service through each vesting date (footnote F1).
- Shares owned after transaction: Not disclosed on this Form 4.
- No sale or purchase of shares occurred in this filing — it documents a compensation award.
Context
This is a standard equity compensation grant for an executive and should be read as a grant of rights to future shares subject to vesting conditions; it is not an immediate purchase or sale. The $0.00 entry on the Form 4 reflects the reporting of a derivative award; exercise price or other grant valuation details (if any) are not specified in the filing and would typically be described in the grant agreement or proxy materials.